Toggle navigation
Home
Search
Services
Blog
Contact
About
Identifying Gene(S) for Alagille Syndrome
Keith, Tim P.
Oscient Pharmaceuticals Corporation, Waltham, MA, United States
Search 7 grants from Tim Keith
Search grants from Oscient Pharmaceuticals Corporation
Share this grant:
:
:
Abstract
Funding
Institution
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Mechanisms of invasion for an HIV related head and neck cancer
RNA Targeted Screens of the Prion 5'UTR
Michigan Center for hES Cell Research
Structure and Assembly of Collagen Molecules and Fibrils
Intermuscular Coordination Movement
Recently added grants:
Necroptotic genes in cancer cellular response to radiation
Studies of the initiation and progression of small cell lung cancer using cells derived by differentiation from human pluripotent stem cells
Optimal BET inhibitor combination therapies in triple negative breast cancer
Pathogenic mechanisms of sinonasal sarcoma, a novel gender dimorphic cancer
Collaborative genomic alterations and transcriptional control in prostate cancer
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Small Business Innovation Research Grants (SBIR) - Phase I (R43)
Project #
1R43DK050900-01
Application #
2017126
Study Section
Special Emphasis Panel (ZRG7-SSS-2 (12))
Project Start
1996-09-30
Project End
1998-03-29
Budget Start
1996-09-30
Budget End
1998-03-29
Support Year
1
Fiscal Year
1996
Total Cost
Indirect Cost
Institution
Name
Oscient Pharmaceuticals Corporation
Department
Type
DUNS #
City
Waltham
State
MA
Country
United States
Zip Code
02453
Comments
Be the first to comment on this grant